Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene.

@article{Martin2001LossOH,
  title={Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene.},
  author={Michelle E. D. Martin and Karl von Fischbach and Charles Osborne and Syed Khalid Mohsin and Donald Craig Allred and Peter O'Connell},
  journal={Cancer research},
  year={2001},
  volume={61 9},
  pages={3578-80}
}
Breast cancer mortality is seldom attributable to the primary tumor, but rather to the presence of systemic (metastatic) disease. Axillary lymph node dissection can identify the presence of metastatic breast cancer cells and serves as a marker for systemic disease. Previous work in our laboratory determined that rates of loss of heterozygosity (LOH) of a 1.6-Mb region of chromosome 14q 31.2 is much higher in axillary lymph node-negative primary breast tumors than in axillary lymph node-positive… CONTINUE READING
14 Citations
17 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Analysis of the complete sequence of the novel metastasisassociated candidate gene , mta 1 , differentially expressed in mammary adenocarcinoma and breast cancer cell lines

  • G. L. Nicolson
  • J . Cell . Biochem .
  • 2000

The dermatomyositisspecific autoantigen Mi 2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

  • D. Reinberg
  • Cell
  • 2000

Loss of heterozygosity at D14S62 and metastatic potential of breast cancer

  • P. O’Connell, S. Hilsenbeck, +4 authors D. C. Allred
  • J. Natl. Cancer Inst.,
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…